Search for:

France, Italy, Germany, Spain, Russia and UK: Top digital health solutions

Whether your company is new to the digital health space, or enhancing its existing digital health offering in response to COVID‑19, here are top legal issues to bear in mind as you embark on your journey.

COVID‑19 is accelerating the adoption of digital health solutions by hospitals and medical institutions around the world. Companies are innovating at lightning speed to adapt to new needs: patients are being treated remotely through mobile doctor apps, symptom-checking bots are triaging patients and providing tailored advice, and new remote consultation and tracking solutions are hitting the market fast.

There has never been a more urgent need to help strained healthcare systems and patients. But even in the current climate, regulators are emphasizing the need to balance innovation and safety.

France

Germany

Italy

Russia

Spain

United Kingdom

 

Author

Magda Tovar joined Baker McKenzie in September 2019 as a Knowledge Lawyer for the Global Healthcare and Life Sciences Industry Group, covering healthcare and life sciences legal issues for -the EMEA region. She also supports the Industry Group at a global level on many knowledge management matters including thought leadership projects and global surveys. Before joining Baker McKenzie, Magda was a senior legal adviser at the European Medicines Agency (EMA) for 16 years where she advised on a broad spectrum of matters related to EU pharmaceutical law, covering medicines for human and veterinary use. She represented the EMA in cases before the General Court and the Court of Justice of the European Union.